Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This experimental dentifrice is a plant-based oral care product developed by researchers at the Federal University of Paraíba (UFPB) in Brazil. The formulation contains a 3.0% hydroalcoholic extract derived from the ripe fruit of *Eugenia uniflora* L., commonly known as Surinam cherry or pitanga. It is designed to treat gingivitis, particularly in pediatric populations, by utilizing the natural antibacterial and anti-inflammatory properties of the extract. The dentifrice targets common oral pathogens such as *Streptococcus mutans*, *Streptococcus oralis*, and *Lactobacillus casei*. In a Phase II clinical trial involving children aged 10-12 years, the product demonstrated significant anti-gingivitis efficacy, reducing gingival bleeding to a degree comparable to triclosan-based controls, although it did not show a significant reduction in dental plaque accumulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Eugenia uniflora dentifrice.